CNS5:Volunteer Assignments and Opportunities: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1,545: | Line 1,545: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]] | |[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]] | ||
| Line 1,556: | Line 1,556: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Schwannomatosis|Schwannomatosis]] | |[[CNS5:Schwannomatosis|Schwannomatosis]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 1,578: | Line 1,578: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]] | |[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 1,600: | Line 1,600: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
!'''Disease''' | !'''Disease''' | ||
| Line 1,622: | Line 1,622: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]] | |[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]] | ||
| Line 1,633: | Line 1,633: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]] | |[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]] | ||
| Line 1,644: | Line 1,644: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]] | |[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]] | |[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Carney_complex|Carney complex]] | |[[CNS5:Carney_complex|Carney complex]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 1,688: | Line 1,688: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]] | |[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]] | |[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 1,736: | Line 1,736: | ||
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]] | |[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 1,754: | Line 1,754: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]] | |[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|} | |} | ||